WebJun 27, 2024 · Free-cysteine residues in recombinant biotherapeutics such as monoclonal antibodies can arise from incorrect cellular processing of disulfide bonds during synthesis or by reduction of disulfide bonds during the harvest and purification stage of manufacture. Free cysteines can affect potency, induce aggregation, and decrease the stability of … WebJan 27, 2024 · System Xc − (a cystine/glutamate antiporter system), belonging to the heterodimeric amino acid transporter (HAT) family, is composed of two subunits, a light-chain subunit SLC7A11 (xCT) and a heavy-chain subunit SLC3A2 (CD98, 4F2hc) [].The two subunits are connected by an extracellular covalent disulfide bond and play different …
Characterization of Antibody–Drug Conjugate Pharmacokinetics …
WebMany immunological methods involve the use of labeled antibodies and a variety of reagents have been created to allow labeling of antibodies. Enzymes, biotin, fluorophores and radioactive isotopes are all commonly … WebApr 18, 2024 · A critical modulator of intracellular redox balance is the system x c – transporter, which mediates the exchange of intracellular glutamate for extracellular cystine, an essential precursor for GSH synthesis. This complex consists of xCT, a light-chain subunit that confers cystine transport function (), and the CD98 heavy-chain subunit, … opusteny dum
High-Throughput Cysteine Scanning To Identify Stable Antibody ...
WebAnti-Cysteine Antibody (3A4) is recommended for use in the following applications: WB (Western blotting), IP (Immunoprecipitation), FCM (Flow Cytometry). Mouse secondary … WebThis antigen affinity purified antibody, in conjunction with PeproTech Biotinylated Anti-Human CTGF (500-P252Bt) as a detection antibody, allows the detection of at least 0.2-0.4 ng/well of Recombinant Human CTGF. Western Blot: To detect Human CTGF by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/mL. WebFeb 9, 2024 · THIOMAB antibody technology utilizes cysteine residues engineered onto an antibody to allow for site-specific conjugation. The technology has enabled the exploration of different attachment sites on the antibody in combination with small molecules, peptides, or proteins to yield antibody conjugates with unique properties. As reported previously … opuss93